Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


4 Am J Med
1 BMC Pediatr
10 BMJ
3 Cell
3 Epidemiol Infect
1 J Infect Dis
1 J Virol
2 MMWR Morb Mortal Wkly Rep
2 N Engl J Med
8 Pediatrics
2 PLoS Biol
1 PLoS Comput Biol
2 PLoS Med
22 PLoS One
2 Proc Natl Acad Sci U S A
4 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Med

  1. JAIN A
    Comments on COVID-19 and AL Amyloidosis, the Missing Links.
    Am J Med. 2022;135:e137-e138.

    COVID-19 and Light Chain Amyloidosis: Correspondence.
    Am J Med. 2022;135:e136.

  3. RAIKHEL AV, Blau KD, Redinger JW
    From Panic to Promise: Harnessing Medical Student Leadership in COVID-19.
    Am J Med. 2022;135:676-677.

  4. TANG H, Tanaka G, Unterman T, Bursztajn H, et al
    Detoxifying the Fear of Epigenetic Changes Due to COVID Vaccination.
    Am J Med. 2022;135:665-666.

    BMC Pediatr

  5. AYED M, Embaireeg A, Kartam M, More K, et al
    Neurodevelopmental outcomes of infants born to mothers with SARS-CoV-2 infections during pregnancy: a national prospective study in Kuwait.
    BMC Pediatr. 2022;22:319.
    PubMed         Abstract available


  6. ABBAS-HANIF A, Modi N, Majeed A
    Long term implications of covid-19 in pregnancy.
    BMJ. 2022;377:e071296.

    The black market for covid-19 antiviral drugs.
    BMJ. 2022;377:o1282.

  8. AU WY, Cheung PP
    Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis.
    BMJ. 2022;377:e069989.
    PubMed         Abstract available

    Covid-19: Partygate makes a mockery of the sacrifices made and the losses endured.
    BMJ. 2022;377:o1358.

  10. Update to living systematic review on covid-19 in pregnancy.
    BMJ. 2022;377:o1205.

  11. TAYLOR L
    Covid-19: Case rises in the Americas driven by increases in North and Central America.
    BMJ. 2022;377:o1355.

  12. MAHASE E
    Sixty seconds on . . . covid rebound.
    BMJ. 2022;377:o1365.

    Living with covid cannot save lives, but research can.
    BMJ. 2022;377:o1361.

  14. BRYCE E, Ong S
    Covid-19 and mRNA technology are helping Africa fix its vaccine problems.
    BMJ. 2022;377:o1196.

  15. TAYLOR L
    Covid-19: Suicide rates fell during Brazil's first wave but increased in older people.
    BMJ. 2022;377:o1351.


  16. GOEL RR, Painter MM, Lundgreen KA, Apostolidis SA, et al
    Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine.
    Cell. 2022;185:1875-1887.
    PubMed         Abstract available

  17. BATLLE D, Monteil V, Garreta E, Hassler L, et al
    Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity.
    Cell. 2022;185:1837-1839.

  18. YEUNG ML, Teng JLL, Yuen KY
    Response to Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity.
    Cell. 2022;185:1840-1841.

    Epidemiol Infect

  19. PARROTT JC, Annibale AM, Osahan S, Alroy K, et al
    Prevalence of SARS-CoV-2 antibodies during phased access to vaccination: results from a population-based survey in New York City, September 2020-March 2021.
    Epidemiol Infect. 2022;150:e105.
    PubMed         Abstract available

  20. EDELMAN NL, Simon P, Cassell JA, Kiss IZ, et al
    Network analysis of England's single parent household COVID-19 control policy impact: a proof-of-concept study.
    Epidemiol Infect. 2022;150:e104.
    PubMed         Abstract available

  21. LONG H, Li J, Li R, Zhang H, et al
    Plasma glucose levels and diabetes are independent predictors for mortality in patients with COVID-19.
    Epidemiol Infect. 2022;150:e106.
    PubMed         Abstract available

    J Infect Dis

  22. HAYDEN FG, Lenk RP, Stonis L, Oldham-Creamer C, et al
    Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials.
    J Infect Dis. 2022 May 26. pii: 6568151. doi: 10.1093.
    PubMed         Abstract available

    J Virol

  23. PRICE GE, Lo CY, Misplon JA, Epstein SL, et al
    Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies.
    J Virol. 2022 May 31:e0032022. doi: 10.1128/jvi.00320.
    PubMed         Abstract available

    MMWR Morb Mortal Wkly Rep

  24. TESEMA L, Sullivan D, Pulido M, Traub E, et al
    Notes from the Field: Influenza A(H3N2) Outbreak Following a School Event - Los Angeles, California, March 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:745-746.

  25. SAPKOTA S, Caruso E, Kobau R, Radhakrishnan L, et al
    Seizure- or Epilepsy-Related Emergency Department Visits Before and During the COVID-19 Pandemic - United States, 2019-2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:703-708.
    PubMed         Abstract available

    N Engl J Med

  26. CREECH CB, Anderson E, Berthaud V, Yildirim I, et al
    Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age.
    N Engl J Med. 2022 May 11. doi: 10.1056/NEJMoa2203315.
    PubMed         Abstract available

  27. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Waning Immunity against Covid-19.
    N Engl J Med. 2022;386:e64.


  28. BOLY TJ, Reyes-Hernandez ME, Daniels EC, Kibbi N, et al
    Hyperglycemia and Cytopenias as Signs of SARS-CoV-2 Delta Variant Infection in Preterm Infants.
    Pediatrics. 2022 Mar 3. pii: 185249. doi: 10.1542/peds.2021-055331.
    PubMed         Abstract available

  29. BREWSTER RC, Parsons C, Laird-Gion J, Hilker S, et al
    COVID-19-Associated Croup in Children.
    Pediatrics. 2022;149.

  30. BOUTZOUKAS AE, Zimmerman KO, Inkelas M, Brookhart MA, et al
    School Masking Policies and Secondary SARS-CoV-2 Transmission.
    Pediatrics. 2022;149.
    PubMed         Abstract available

  31. RAO S, Hurst JH, Zhao C, Goldstein BA, et al
    Asthma and the Risk of SARS-CoV-2 Infection Among Children and Adolescents.
    Pediatrics. 2022 Mar 11. pii: 185387. doi: 10.1542/peds.2021-056164.
    PubMed         Abstract available

  32. CRUZ AT, Denison MR
    Integrating SARS-CoV-2 Antibody Results in Children Into Pandemic Response.
    Pediatrics. 2022;149.

  33. MESSIAH SE, DeSantis SM, Leon-Novelo LG, Talebi Y, et al
    Durability of SARS-CoV-2 Antibodies From Natural Infection in Children and Adolescents.
    Pediatrics. 2022;149.

  34. RAHMAN R, Huysman C, Ross AM, Boskey ER, et al
    Intimate Partner Violence and the COVID-19 Pandemic.
    Pediatrics. 2022;149.
    PubMed         Abstract available

  35. SCOTTONI F, Giobbe GG, Zambaiti E, Khalaf S, et al
    Intussusception and COVID-19 in Infants: Evidence for an Etiopathologic Correlation.
    Pediatrics. 2022 Mar 24. pii: 185620. doi: 10.1542/peds.2021-054644.
    PubMed         Abstract available

    PLoS Biol

  36. RICE BL, Lessler J, McKee C, Metcalf CJE, et al
    Why do some coronaviruses become pandemic threats when others do not?
    PLoS Biol. 2022;20:e3001652.
    PubMed         Abstract available

  37. SYENINA A, Gan ES, Toh JZN, de Alwis R, et al
    Adverse effects following anti-COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes.
    PLoS Biol. 2022;20:e3001643.
    PubMed         Abstract available

    PLoS Comput Biol

  38. KOSLOW W, Kuhn MJ, Binder S, Klitz M, et al
    Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant.
    PLoS Comput Biol. 2022;18:e1010054.
    PubMed         Abstract available

    PLoS Med

  39. BUITRAGO-GARCIA D, Ipekci AM, Heron L, Imeri H, et al
    Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis.
    PLoS Med. 2022;19:e1003987.
    PubMed         Abstract available

  40. ANNWEILER C, Beaudenon M, Gautier J, Gonsard J, et al
    High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial.
    PLoS Med. 2022;19:e1003999.
    PubMed         Abstract available

    PLoS One

  41. AL-RASHEDI NAM, Alburkat H, Hadi AO, Munahi MG, et al
    High prevalence of an alpha variant lineage with a premature stop codon in ORF7a in Iraq, winter 2020-2021.
    PLoS One. 2022;17:e0267295.
    PubMed         Abstract available

  42. ROSENTHAL EM, Rosenberg ES, Patterson W, Ferguson WP, et al
    Factors associated with SARS-CoV-2-related hospital outcomes among and between persons living with and without diagnosed HIV infection in New York State.
    PLoS One. 2022;17:e0268978.
    PubMed         Abstract available

  43. WEBER S, Kehl V, Erber J, Wagner KI, et al
    CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients.
    PLoS One. 2022;17:e0268530.
    PubMed         Abstract available

  44. WAGNER CS, Cai X, Zhang Y, Fry CV, et al
    One-year in: COVID-19 research at the international level in CORD-19 data.
    PLoS One. 2022;17:e0261624.
    PubMed         Abstract available

  45. WIWATTANAPANTUWONG J, Tuicomepee A, Suttiwan P, Watakakosol R, et al
    For better or worse: Relationship change in Thailand during COVID-19.
    PLoS One. 2022;17:e0264614.
    PubMed         Abstract available

  46. WARSZAWSKI J, Meyer L, Franck JE, Rahib D, et al
    Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort-EPICOV.
    PLoS One. 2022;17:e0267725.
    PubMed         Abstract available

  47. ASRI A, Asri V, Renerte B, Follmi-Heusi F, et al
    Which hospital workers do (not) want the jab? Behavioral correlates of COVID-19 vaccine willingness among employees of Swiss hospitals.
    PLoS One. 2022;17:e0268775.
    PubMed         Abstract available

  48. LI Z, Bruce JL, Cohen B, Cunningham CV, et al
    Development and implementation of a simple and rapid extraction-free saliva SARS-CoV-2 RT-LAMP workflow for workplace surveillance.
    PLoS One. 2022;17:e0268692.
    PubMed         Abstract available

  49. KAGGWA MM, Abaatyo J, Alol E, Muwanguzi M, et al
    Substance use disorder among adolescents before and during the COVID-19 pandemic in Uganda: Retrospective findings from a psychiatric ward registry.
    PLoS One. 2022;17:e0269044.
    PubMed         Abstract available

  50. KIENINGER M, Dietl S, Sinning A, Gruber M, et al
    Evaluation of models for prognosing mortality in critical care patients with COVID-19: First- and second-wave data from a German university hospital.
    PLoS One. 2022;17:e0268734.
    PubMed         Abstract available

  51. TAKAHASHI H, Terada I, Higuchi T, Takada D, et al
    The relationship between new PCR positive cases and going out in public during the COVID-19 epidemic in Japan.
    PLoS One. 2022;17:e0266342.
    PubMed         Abstract available

  52. ZHANG Y, Pi DD, Liu CJ, Li J, et al
    Psychological impact of the COVID-19 epidemic among healthcare workers in paediatric intensive care units in China.
    PLoS One. 2022;17:e0265377.
    PubMed         Abstract available

  53. PIOVANO E, Pagano E, Del Piano E, Rinaldi F, et al
    Implementation of the ERAS (Enhanced Recovery After Surgery) protocol for hysterectomy in the Piedmont Region with an audit&feedback approach: Study protocol for a stepped wedge cluster randomized controlled trial. A study of the EASY-NET project.
    PLoS One. 2022;17:e0268655.
    PubMed         Abstract available

  54. KUBOTA J, Takahashi S, Suzuki T, Ito A, et al
    Pranlukast treatment and the use of respiratory support in infants with respiratory syncytial virus infection.
    PLoS One. 2022;17:e0269043.
    PubMed         Abstract available

  55. JAHAN F, Kennedy DW, Duncan EW, Mengersen KL, et al
    Evaluation of spatial Bayesian Empirical Likelihood models in analysis of small area data.
    PLoS One. 2022;17:e0268130.
    PubMed         Abstract available

  56. LAMPART M, Zellweger N, Bassetti S, Tschudin-Sutter S, et al
    Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections-A prospective cohort study.
    PLoS One. 2022;17:e0269005.
    PubMed         Abstract available

  57. HAGEMO JS, Skulberg AK, Rehn M, Valberg M, et al
    Inhaled nitric oxide as temporary respiratory stabilization in patients with COVID-19 related respiratory failure (INOCOV): Study protocol for a randomized controlled trial.
    PLoS One. 2022;17:e0268822.
    PubMed         Abstract available

  58. MARIANI J, Antonietti L, Tajer C, Ferder L, et al
    High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: Multicentre randomized controlled clinical trial.
    PLoS One. 2022;17:e0267918.
    PubMed         Abstract available

    Dynamic topic modeling of twitter data during the COVID-19 pandemic.
    PLoS One. 2022;17:e0268669.
    PubMed         Abstract available

  60. ESCRIBANO VILLAFRUELA J, de Urquia Cobo A, Martin Luengo F, Anton Modrego V, et al
    Changing trends in ophthalmological emergencies during the COVID-19 pandemic.
    PLoS One. 2022;17:e0268975.
    PubMed         Abstract available

  61. WANG L, Ding Y, Zhang C, Chen R, et al
    Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients.
    PLoS One. 2022;17:e0269249.
    PubMed         Abstract available

  62. KHATER I, Nassar A
    Seeking antiviral drugs to inhibit SARS-CoV-2 RNA dependent RNA polymerase: A molecular docking analysis.
    PLoS One. 2022;17:e0268909.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  63. LEECH G, Rogers-Smith C, Monrad JT, Sandbrink JB, et al
    Mask wearing in community settings reduces SARS-CoV-2 transmission.
    Proc Natl Acad Sci U S A. 2022;119:e2119266119.
    PubMed         Abstract available

  64. A global experiment on motivating social distancing during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2022;119:e2111091119.
    PubMed         Abstract available


  65. WIEMKEN TL, Salas J, Hoft DF, Jacobs C, et al
    In response to: JVAC-D-21-02863, detection of a potential error in the results of the manuscript, dementia risk following influenza vaccination in a large veteran cohort, that could call into question the main conclusion.
    Vaccine. 2022;40:3529.

  66. VUICHARD-GYSIN D, Schoenenberger A
    Detection of a potential error in the results of the manuscript "Dementia risk following influenza vaccination in a large veteran cohort" that could eventually call into question the main conclusion.
    Vaccine. 2022;40:3528.

  67. SHIOHARA M, Suzuki S, Shichinohe S, Ishigaki H, et al
    Inactivated whole influenza virus particle vaccines induce neutralizing antibodies with an increase in immunoglobulin gene subclones of B-lymphocytes in cynomolgus macaques.
    Vaccine. 2022 May 28. pii: S0264-410X(22)00640.
    PubMed         Abstract available

  68. LAI X, Li M, Hou Z, Guo J, et al
    Factors associated with caregivers' hesitancy to vaccinate children against influenza: A cross-sectional survey in China.
    Vaccine. 2022 May 27. pii: S0264-410X(22)00606.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.